Choksi Laboratories P/E Ratio
Current P/E Ratio
58.45
High Valuation
Very High - High growth expectations or significantly overvalued
Choksi Laboratories P/E ratio. Choksi Laboratories (CHOKSILA) P/E ratio is 58.45 (High), EPS (TTM) ₹2.82, current price ₹183.30 on BSE — Very High - High growth expectations or significantly overvalued. Check Choksi Laboratories market worth to track the company's total market size over time.
Current Valuation Metrics
P/E Ratio
58.45
Current Price
₹183.30
EPS (TTM)
₹2.82
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
94.23
Sector Median
43.09
Sector Rank
#11 of 57
Sector Percentile
19.3%
CHOKSILA P/E Ratio — Valuation Signal & Historical Context
Choksi Laboratories P/E 58.45 — signal: Overvalued. Also explore CHOKSILA share price data to track price trends across different timeframes.
- Stock appears overvalued with PE of 58.45, suggesting caution for new investments
- Trading at discount to sector average PE of 94.23
CHOKSILA vs Healthcare Services Peers — P/E Ratio Comparison
Choksi Laboratories P/E 58.45 vs Healthcare Services average 94.23, median 43.09 — range 6.97–1642.14.
Sector Average
94.23
Sector Median
43.09
Lowest P/E
6.97
Highest P/E
1642.14
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.97 | ₹131 | Low |
| Abate AS Industries | ABATEAS | 10.23 | ₹122 | Low |
| Deccan Health Care | DECCAN | 11.6 | ₹29 | Low |
| Nidan Labs & Healthcare | NIDAN | 11.94 | ₹17 | Low |
| One Global Service Provi… | ONEGLOBAL | 13.97 | ₹1,027 | Low |
| Shanmuga Hospital | SHANMUGA | 14.42 | ₹61 | Low |
| Indraprastha Medical Cor… | INDRAMEDCO | 16.52 | ₹3,061 | Moderate |
| Invicta Diagnostic | INVICTA | 17.24 | ₹85 | Moderate |
| Dhanvantri Jeevan Rekha | ZDHJERK | 18.19 | ₹9 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.62 | ₹1,793 | Moderate |